STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Recruiting
- Non-cirrhotic, Chronic Hepatitis B
- Tenofovir alafenamide fumarate
- New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
2022-02-23
Feb 23, 2022D
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
- +5 more
- Beijing, Beijing, ChinaPeking University Peoples Hospital
2021-02-16
Feb 16, 2021A
I
Recruiting
- Gastric Cancer
- +3 more
- MELD-Na score
- Istanbul, TurkeyIstanbul Training and Research Hospital
2021-03-06
Mar 6, 2021T
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- TERN-201
- Placebo
- Tucson, Arizona
- +10 more
2022-02-14
Feb 14, 2022U
Completed
- Cystic Fibrosis Liver Disease
- +2 more
- TIPS
- (no location specified)
2021-08-30
Aug 30, 2021M
Recruiting
- Hepatitis C
- Sofosbuvir 400 MG
- Ravidasvir 200mg
- Alor Star, Kedah, MalaysiaHospital Sultanah Bahiyah
2021-05-17
May 17, 2021F
Terminated
- Hepatitis B
- +2 more
- Inarigivir soproxil
- Tenofovir alafenamide fumarate (TAF)
- Hong Kong, Hong Kong Island, Hong Kong
- +1 more
2020-07-20
Jul 20, 2020N
Recruiting
- Cystic Fibrosis
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022A
U
Recruiting
- Liver Cirrhosis
- +4 more
- No Intervention
- Bonn, GermanyUniversity Hospital Bonn
2020-10-06
Oct 6, 2020H
Active, not recruiting
- Chronic Hepatitis C
- Telemedicine
- Velpatasvir/Sofosbuvir
- Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
2021-08-24
Aug 24, 2021M
Recruiting
- Vascular Liver Disease
- +5 more
- Vienna, AustriaMedical University of Vienna
2020-10-31
Oct 31, 2020D
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- TG-2349
- +2 more
- Beijing, ChinaBeijing Tsinghua Changgung Hospital
2021-02-02
Feb 2, 2021T
Completed
- NASH - Nonalcoholic Steatohepatitis
- TERN-101
- Placebo
- Chandler, Arizona
- +30 more
2021-08-03
Aug 3, 2021M
Terminated
- Hepatitis C
- Dublin, IrelandThompson Centre
2019-12-06
Dec 6, 2019A
Active, not recruiting
- NASH - Nonalcoholic Steatohepatitis
- EFX
- Placebo
- Chandler, Arizona
- +53 more
2022-02-10
Feb 10, 2022N
Completed
- Hepatitis Viruses
- Chiayi City, Taiwan
- +7 more
2019-05-10
May 10, 2019U
Recruiting
- Hepatic Insufficiency
- Hepatobiliary scintigraphy
- Amiens, France
- +11 more
2020-11-18
Nov 18, 2020M
Completed
- Non-alcoholic Steatohepatitis
- Placebo
- +2 more
- Boston, Massachusetts
- +5 more
2019-07-08
Jul 8, 2019U
Unknown status
- Liver Metastasis Colon Cancer
- Liver preparation before major hepatectomy
- Montpellier, Hérault, France
- +11 more
2020-04-23
Apr 23, 2020A
Completed
- Hepatitis C Virus (HCV)
- Placebo
- Glecaprevir/Pibrentasvir
- Beijing, Beijing, China
- +47 more
2019-12-05
Dec 5, 2019M
A
Terminated
- Hepatitis B
- +4 more
- ALN-HBV
- Sterile Normal Saline (0.9% NaCl)
- Adelaide, South Australia, Australia
- +8 more
2018-09-20
Sep 20, 2018G
Active, not recruiting
- Primary Sclerosing Cholangitis
- Cilofexor
- Placebo
- Glendale, Arizona
- +200 more
2021-08-27
Aug 27, 2021